Bogalusa Heart Study

Study acronym: BHS
StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Nov 2024 to Nov 2029
    • Start date: Jun 1972 to Aug 1973
    v14
  2. Eligibility criteria expanded, about 57 wordsv13
  3. Re-verified, no change to tracked fieldsv12
  4. Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Enrollment target: 12000 to 11737
    v11
  5. Primary and study completion dates: Nov 2023 to Nov 2024v10
Show 8 earlier versionsHide 8 earlier versions
  1. Trial status: Active, Not Recruiting to Enrolling by Invitationv9
  2. Primary and study completion dates: Nov 2019 to Nov 2023
    • Publications: 626 to 654
    • Study description shortened, about 1 word
    v8
  3. Study description expanded, about 16 words
    • Publications: 475 to 626
    v7
  4. Trial status: Recruiting to Active, Not Recruitingv6 Show 7 more changesShow less
    • Enrollment target: 12000
    • Primary completion date: Nov 2019
    • Study completion date: Jul 2002 to Nov 2019
    • Study description expanded, about 26 words
    • Site details revised
    • Collaborators: 2 to 4
    • Eligibility criteria expanded, about 5 words
  5. Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI) to Tulane University
    • Trial status: Completed to Recruiting
    • Study sites: 0 to 1
    • Collaborators expanded, about 12 words
    v5
  6. Publications: 339 to 475v4
  7. Publications: 334 to 339v3
  8. Publications: 333 to 334v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tulane University
47 trials monitored
See 8 trials at risk
Heart Disease
8,870 trials monitored
See 440 trials at risk
Hypertension
1,945 trials monitored
See 102 trials at risk
To determine the natural history of atherosclerosis, coronary artery disease, and hypertension in children and adults from birth through mid-life in a total biracial community.
Trial Details
NCT Number NCT00005129
Lead Sponsor Tulane University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS)
Conditions
(from sponsor)		 Atherosclerosis, Cardiovascular Diseases, Heart Diseases, Coronary Disease, Hypertension
Related terms Atherosclerosis, Cardiovascular Diseases, Coronary Disease, Heart Diseases, Hypertension
Enrollment 11,737 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov